The Influence of Glucagon-like Peptide-1 Receptor Agonists on Outcomes Following Trigger Finger Release

Key Points

• Outcomes improve significantly in patients using glucagon-like peptide-1 receptor agonists following trigger finger release, enhancing recovery overall.
• The most critical improvement observed was in mobility and pain levels among patients, indicating a notable therapeutic benefit.
• Analysis demonstrates how glucagon-like peptide-1 receptor agonists can be integrated with surgical interventions for better recovery.
• This study may enable clinicians to consider glucagon-like peptide-1 receptor agonists as part of standard post-surgical care for trigger finger.